세계 펩티드 합성 시장 규모는 2023년 901억 달러에서 예측 기간 동안 11.8%의 연평균 복합 성장률(CAGR)로 2028년 말까지 1,575억 달러 규모로 성장할 것으로 예상됩니다.
세계 펩티드 합성 시장 규모는 2023년 283억 달러에서 2028년 말에는 516억 달러에 달할 것으로 예상되며, 같은 기간 동안 12.8%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 세계 생리활성 펩티드 시장 규모는 2023년 183억 달러에서 연평균 12.6% 성장하여 2028년 말에는 330억 달러에 달할 것으로 예상됩니다.
세계 펩티드 합성(Peptide Synthesis) 시장을 조사했으며, 시장 개요, 규제 환경, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
시장 구분 :
펩티드 유형별
펩티드 합성
항균 펩티드
호르몬 펩티드
생물학적 활성 펩티드
콜라겐 펩티드
기타
용도별
암
당뇨병
신경
기타(심장병, 희귀질환 등)
펩티드 치료제
화장품
영양 보충제
기타(신약 개발, 의료용 영상진단)
합성 유형별:
Solid-phase
Solution-phase
Hybrid-phase
목차
제1장 주요 요약
시장 전망
조사 범위
시장 개요
제2장 시장 개요
펩티드 치료
펩티드의 중요성
펩티드 합성
펩티드 치료 동향
제3장 시장 역학
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
제4장 펩티드 합성과 치료제 제조을 위한 신기술
수성 매체에서의 SPPS 진보
화학 합성
펩티드 약물전달
신개발 사례 : 기업별
Nissan Chemical Corp.
Gyros Protein Technologies AB
제5장 시장 분석 : 각종 구분별
분류 내역
세계의 펩티드 합성 시장 : 펩티드 유형별
펩티드 합성
항균 펩티드
호르몬 펩티드
생리활성 펩티드
콜라겐 펩티드
기타
세계의 펩티드 합성 시장 : 용도별
펩티드 치료
화장품
식이보충제
기타
세계의 펩티드 합성 시장 : 합성 유형별
Solid-phase
Solution-phase
Hybrid-phase
세계의 펩티드 합성 시장 : 지역별
북미
유럽
아시아태평양
기타 지역
제6장 경쟁 구도
주요 기업
전략 분석
인수합병(M&A) 분석
인수합병(M&A) 거래
성장하는 바이오테크놀러지 신규 기업
Neumora Therapeutics Inc.
Altos Labs
Affini-T Therapeutics
Capstan Therapeutics
Septerna Inc.
제7장 펩티드 합성 산업의 지속가능성 : ESG 관점
펩티드 치료제 제조업체에서 ESG의 중요성
펩티드 치료제 제조업체의 ESG 실천
BCC에 의한 시점
제8장 부록
조사 방법
참고 문헌
기업 개요
ABBOTT
ABBVIE INC.
AMGEN INC.
ASTRAZENECA
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL MYERS SQUIBB CO.
B. BRAUN SE
LILLY
MERCK & CO. INC.
MODERNA INC.
NOVARTIS AG
NOVO NORDISK A/S
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.
LSH
영문 목차
영문목차
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
The global market for synthetic peptides is expected to grow from $28.3 billion in 2023 and projected to reach $51.6 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.8% during the forecast period of 2023 to 2028.
The global market for bioactive peptides is expected to grow from $18.3 billion in 2023 and projected to reach $33.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Report Scope
The report provides a detailed summary of the peptide synthesis market, with a focus on peptide therapeutics; a competitive landscape; and company profiles that include revenue, product portfolio and news in development. The report analyzes market trends and dynamics, including drivers, restraints and opportunities. This research study discusses historical year, base year and potential market size for the forecast period.
The report will enable key players, other strategists and start-ups to make informed decisions about the production, marketing and licensing of goods and services. Organizations, exporters and distributors should find the information about market development and trends useful. The segments of the market provided in the report are peptide type, applications and synthesis type. Regional market analysis is provided for all segments, and country-level analysis in some cases. Key developments and ESG information for the companies is provided based on the market.
The market is divided into segments and by application/industry as follows:
By peptide types:
Synthetic peptides.
Antimicrobial peptides.
Hormonal peptides.
Bioactive peptides.
Collagen peptides.
Others.
By application:
Cancer.
Diabetes.
Neurology.
Others (cardiology, rare diseases, etc.).
Peptide therapeutics.
Cosmetics.
Nutraceuticals.
Others (drug discovery, medical imaging).
By synthesis type:
Solid-phase.
Solution-phase.
Hybrid-phase.
For each of these areas, current products in the market are identified, measuring the market size and identifying potential market drivers. Forecasts for 2028 are attained by analyzing the current competitors' market shares for the base year of 2022. A top-down approach was also followed to determine peptide synthesis market shares in 2022 by consulting secondary and primary sources.
By geographic region, the market is segmented into North America, Europe, Asia-Pacific and the Rest of World. The markets in countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico and GCC countries are analyzed. For market estimates, data is provided for 2022 as the base year, with estimates for 2023 and forecast values for 2028.
Report Includes
63 data tables and 56 additional tables
An overview of the global market for peptide synthesis
Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Estimate of the actual market size and revenue forecast, and a corresponding market share analysis by product type, synthesis area, application, end-user, and region
Facts and figures pertaining to major market dynamics, technological trends, latest developments in peptide production, pipeline drugs (manufactured using peptides), and future prospects
Discussion of sustainability trends and factors, with emphasis on consumer attitudes, companies' ESG scores, the future of ESG, case studies and the ESG practices of companies
Overview of the major vendors along with an analysis of the industry structure, including company market shares, recent M&A activity and venture funding outlook
Competitive intelligence on the leading market players, including their product developments, business strategies, key financials and segmental revenues
Profiles of the leading global players, including Novo Nordisk A/S., AbbVie Inc., Lilly, Novartis Ag, AstraZeneca, and Teva Pharmaceutical
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Peptide Therapeutics
Importance of Peptides
Peptide Synthesis
Trends in Peptide Therapeutics
Chapter 3 Market Dynamics
Market Drivers
Overview
Rising Incidence of Chronic Diseases
Developments in Peptide Drug Delivery
Increase in Biotech Spending
Increase in Infectious and Chronic Diseases
Market Restraints
Issues in Sustainability in Synthetic Peptide Production
Market Opportunities
Oral Peptide Therapeutics
Opportunities in Emerging Nations
Chapter 4 Emerging Technologies for Peptide Synthesis and Therapeutics Manufacturing
Introduction
Advances in SPPS in Aqueous Media
Chemical Synthesis
Peptide Drug Delivery
Examples of New Developments, by Company
Nissan Chemical Corp.
Gyros Protein Technologies AB
Chapter 5 Market Analysis, by Segment
Segmentation Breakdown
Peptide Synthesis by Peptide Type
Global Market for Peptide Synthesis, by Peptide Type
Synthetic Peptides
Antimicrobial Peptides
Hormonal Peptides
Bioactive Peptides
Collagen Peptides
Other Products
Global Market for Peptide Synthesis, by Application
Peptide Therapeutics
Cosmetics
Nutraceuticals
Other Types of Applications
Peptide Synthesis by Synthesis Type
Global Market for Peptide Synthesis by Synthesis Type
Solid-phase
Solution-phase
Hybrid-phase
Peptide Synthesis by Region
Regional Breakdown
Global Market for Peptide Synthesis, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Landscape
Top Players
Strategic Analysis
M&A Analysis
M&A Deals in 2020-2023
Flourishing Biotech Startups (2023)
Neumora Therapeutics Inc.
Altos Labs
Affini-T Therapeutics
Capstan Therapeutics
Septerna Inc.
Chapter 7 Sustainability in the Peptide Synthesis Industry: An ESG Perspective
Importance of ESG among Peptide Therapeutics Manufacturers
ESG Practices of Peptide Therapeutics Manufacturers
